Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AusBiotech does not conduct clinical trials or develop products itself. It serves as Australia’s leading biotechnology industry organization, representing over 3,000 members across human health, medical devices and diagnostics, agricultural biotech, and related sectors. It provides advocacy, networking opportunities—including the flagship annual conference—and support for commercialization and growth of the life sciences sector in Australia[1][2][3].
The organization has played a key role in uniting stakeholders across academia, industry startups to multinationals, research institutes and service providers for more than 35 years[1][4].
Its initiatives include policy advocacy at state and federal levels and programs to drive sustainability and global market access for Australian bioscience[1][2].
The annual AusBiotech International Conference draws national and international participants to showcase innovation and foster partnerships[3].
As an association rather than a product company or CRO/CMO/CDMO/etc., it does not have its own R&D pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AusBiotech.